{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:05:55Z","timestamp":1792807555247,"version":"4.5.0"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hermansky\u2013Pudlak syndrome (HPS) is a rare autosomal recessive genetic disorder characterized by oculocutaneous albinism and a bleeding diathesis due to platelet dysfunction. More than 50% of cases worldwide are diagnosed on the Caribbean island of Puerto Rico. Genetic testing plays a growing role in diagnosis; however, not all patients with HPS have identified genetic mutations. In Puerto Rico, patients with HPS are often identified shortly after birth by their albinism, although the degree of hypopigmentation is highly variable. Ten subtypes have been described. Patients with HPS-1, HPS-2, and HPS-4 tend to develop pulmonary fibrosis in Puerto Rico; 100% of patients with HPS-1 develop HPS-PF. HPS-PF and idiopathic pulmonary fibrosis are considered similar entities (albeit with distinct causes) because both can show similar histological disease patterns. However, in contrast to idiopathic pulmonary fibrosis, HPS-PF manifests much earlier, often at 30\u201340 years of age. The progression of HPS-PF is characterized by the development of dyspnea and increasingly debilitating hypoxemia. No therapeutic interventions are currently approved by the U.S. Food and Drug Administration for the treatment of HPS and HPS-PF. However, the approval of two new antifibrotic drugs, pirfenidone and nintedanib, has prompted new interest in identifying drugs capable of reversing or halting the progression of HPS-PF. Thus, lung transplantation remains the only potentially life-prolonging treatment. At present, two clinical trials are recruiting patients with HPS-PF to identify biomarkers for disease progression. Advances in the diagnosis and management of these patients will require the establishment of multidisciplinary centers of excellence staffed by experts in this disease.<\/jats:p>","DOI":"10.1513\/annalsats.201603-186fr","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T16:06:49Z","timestamp":1471363609000},"page":"1839-1846","source":"Crossref","is-referenced-by-count":39,"title":["Pulmonary Fibrosis in Hermansky\u2013Pudlak Syndrome"],"prefix":"10.1093","volume":"13","author":[{"given":"Glenn W.","family":"Vicary","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Disorders Medicine, Department of Medicine, and Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeidyly","family":"Vergne","sequence":"additional","affiliation":[{"name":"Department of Public Health, Ponce Health Sciences University, Ponce, Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Santiago-Cornier","sequence":"additional","affiliation":[{"name":"Department of Public Health, Ponce Health Sciences University, Ponce, Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Young","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, and Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Roman","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Disorders Medicine, Department of Medicine, and Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky"},{"name":"Louisville Robley Rex Veterans Affairs Medical Center, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,10,1]]},"reference":[{"key":"2026020402524458400_bib1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2147\/CLEP.S54815","article-title":"Epidemiology of idiopathic pulmonary fibrosis","volume":"5","author":"Ley","year":"2013","journal-title":"Clin Epidemiol"},{"key":"2026020402524458400_bib2","doi-asserted-by":"crossref","first-page":"L441","DOI":"10.1152\/ajplung.00335.2011","article-title":"Right place, right time: the evolving role of herpesvirus infection as a \u201csecond hit\u201d in idiopathic pulmonary fibrosis","volume":"302","author":"Kropski","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026020402524458400_bib3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00439-003-1015-4","article-title":"Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis","volume":"113","author":"Selman","year":"2003","journal-title":"Hum Genet"},{"key":"2026020402524458400_bib4","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1164\/rccm.200112-123OC","article-title":"Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred","volume":"165","author":"Thomas","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402524458400_bib5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","article-title":"A common MUC5B promoter polymorphism and pulmonary fibrosis","volume":"364","author":"Seibold","year":"2011","journal-title":"N Engl J Med"},{"key":"2026020402524458400_bib6","first-page":"8, 11","article-title":"Short telomeres in pulmonary fibrosis: from genetics to clinical significance","volume":"64","author":"Tr\u0103il\u0103","year":"2015","journal-title":"Pneumologia"},{"key":"2026020402524458400_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/pcmr.12438","article-title":"Identification and clinical characterization of Hermansky\u2013Pudlak syndrome alleles in the Pakistani population","volume":"29","author":"Yousaf","year":"2016","journal-title":"Pigment Cell Melanoma Res"},{"key":"2026020402524458400_bib8","article-title":"Hermansky\u2013Pudlak syndrome","volume-title":"GeneReviews [2000 Jul 24; updated 2014 Dec 11; accessed 2016 Aug 27]","author":"Gahl"},{"key":"2026020402524458400_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.jid.5700034","article-title":"Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky\u2013Pudlak syndrome type 1 and 3 mutations in Puerto Rico","volume":"126","author":"Santiago Borrero","year":"2006","journal-title":"J Invest Dermatol"},{"key":"2026020402524458400_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/13816819009020986","article-title":"Hermansky\u2013Pudlak syndrome (HPS): an epidemiologic study","volume":"11","author":"Witkop","year":"1990","journal-title":"Ophthalmic Paediatr Genet"},{"key":"2026020402524458400_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V14.2.162.162","article-title":"Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies","volume":"14","author":"Hermansky","year":"1959","journal-title":"Blood"},{"key":"2026020402524458400_bib12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/bies.20042","article-title":"Murine Hermansky\u2013Pudlak syndrome genes: regulators of lysosome-related organelles","volume":"26","author":"Li","year":"2004","journal-title":"BioEssays"},{"key":"2026020402524458400_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0749.2005.00289.x","article-title":"Hermansky\u2013Pudlak syndrome: a disease of protein trafficking and organelle function","volume":"19","author":"Wei","year":"2006","journal-title":"Pigment Cell Res"},{"key":"2026020402524458400_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5482\/HAMO-14-06-0024","article-title":"Hermansky\u2013Pudlak syndrome: overview of clinical and molecular features and case report of a new HPS-1 variant","volume":"34","author":"S\u00e1nchez-Guiu","year":"2014","journal-title":"Hamostaseologie"},{"key":"2026020402524458400_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/2156-7514.143437","article-title":"Hermansky\u2013Pudlak syndrome complicated by pulmonary fibrosis: radiologic\u2013pathologic correlation and review of pulmonary complications","volume":"4","author":"Kelil","year":"2014","journal-title":"J Clin Imaging Sci"},{"key":"2026020402524458400_bib16","first-page":"333","article-title":"Albinism and Hermansky\u2013Pudlak syndrome in Puerto Rico","volume":"82","author":"Witkop","year":"1990","journal-title":"Bol Asoc Med P R"},{"key":"2026020402524458400_bib17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng576","article-title":"Mutation of a new gene causes a unique form of Hermansky\u2013Pudlak syndrome in a genetic isolate of central Puerto Rico","volume":"28","author":"Anikster","year":"2001","journal-title":"Nat Genet"},{"key":"2026020402524458400_bib18","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1038\/jid.2011.228","article-title":"Clinical, molecular, and cellular features of non\u2013Puerto Rican Hermansky\u2013Pudlak syndrome patients of Hispanic descent","volume":"131","author":"Carmona-Rivera","year":"2011","journal-title":"J Invest Dermatol"},{"key":"2026020402524458400_bib19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ng1196-300","article-title":"Positional cloning of a gene for Hermansky\u2013Pudlak syndrome, a disorder of cytoplasmic organelles","volume":"14","author":"Oh","year":"1996","journal-title":"Nat Genet"},{"key":"2026020402524458400_bib20","first-page":"550","article-title":"Hermansky\u2013Pudlak syndrome: report of a case and review of the literature","volume":"1","author":"Hurford","year":"2008","journal-title":"Int J Clin Exp Pathol"},{"key":"2026020402524458400_bib21","doi-asserted-by":"crossref","first-page":"20332","DOI":"10.1074\/jbc.M300090200","article-title":"The Hermansky\u2013Pudlak syndrome 1 (HPS1) and HPS4 proteins are components of two complexes, BLOC-3 and BLOC-4, involved in the biogenesis of lysosome-related organelles","volume":"278","author":"Chiang","year":"2003","journal-title":"J Biol Chem"},{"key":"2026020402524458400_bib22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1203\/00006450-200202000-00006","article-title":"Nonsense mutations in ADTB3A cause complete deficiency of the \u03b23A subunit of adaptor complex-3 and severe Hermansky\u2013Pudlak syndrome type 2","volume":"51","author":"Huizing","year":"2002","journal-title":"Pediatr Res"},{"key":"2026020402524458400_bib23","first-page":"76","article-title":"Hermansky\u2013Pudlak syndrome complicated by pulmonary fibrosis","volume":"25","author":"Carter","year":"2012","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"2026020402524458400_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1083\/jcb.200606050","article-title":"Rab38 and Rab32 control post-Golgi trafficking of melanogenic enzymes","volume":"175","author":"Wasmeier","year":"2006","journal-title":"J Cell Biol"},{"key":"2026020402524458400_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1160\/TH14-11-0999","article-title":"A review of platelet secretion assays for the diagnosis of inherited platelet secretion disorders","volume":"114","author":"Mumford","year":"2015","journal-title":"Thromb Haemost"},{"key":"2026020402524458400_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ymgme.2014.11.006","article-title":"In vitro functional correction of Hermansky\u2013Pudlak syndrome type-1 by lentiviral-mediated gene transfer","volume":"114","author":"Ikawa","year":"2015","journal-title":"Mol Genet Metab"},{"key":"2026020402524458400_bib27","doi-asserted-by":"crossref","first-page":"L461","DOI":"10.1152\/ajplung.00056.2011","article-title":"Rab38 targets to lamellar bodies and normalizes their sizes in lung alveolar type II epithelial cells","volume":"301","author":"Zhang","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026020402524458400_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/mgme.1998.2729","article-title":"Hermansky\u2013Pudlak syndrome: models for intracellular vesicle formation","volume":"65","author":"Shotelersuk","year":"1998","journal-title":"Mol Genet Metab"},{"key":"2026020402524458400_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1542\/peds.2012-4003","article-title":"Hermansky\u2013Pudlak syndrome: health care throughout life","volume":"132","author":"Seward","year":"2013","journal-title":"Pediatrics"},{"key":"2026020402524458400_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","article-title":"American Thoracic Society\/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias","volume":"165","author":"American Thoracic Society; European Respiratory Society","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402524458400_bib31","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402524458400_bib32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1096-7192(02)00044-6","article-title":"Effect of pirfenidone on the pulmonary fibrosis of Hermansky\u2013Pudlak syndrome","volume":"76","author":"Gahl","year":"2002","journal-title":"Mol Genet Metab"},{"key":"2026020402524458400_bib33","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet"},{"key":"2026020402524458400_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1513\/pats.201201-011AW","article-title":"Genesis of the myofibroblast in lung injury and fibrosis","volume":"9","author":"Phan","year":"2012","journal-title":"Proc Am Thorac Soc"},{"key":"2026020402524458400_bib35","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200901-0023OC","article-title":"Alveolar macrophage dysregulation in Hermansky\u2013Pudlak syndrome type 1","volume":"180","author":"Rouhani","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402524458400_bib36","doi-asserted-by":"crossref","first-page":"L1038","DOI":"10.1152\/ajplung.00167.2003","article-title":"Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice","volume":"286","author":"Inoshima","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026020402524458400_bib37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2353\/ajpath.2008.070726","article-title":"Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis","volume":"172","author":"Henderson","year":"2008","journal-title":"Am J Pathol"},{"key":"2026020402524458400_bib38","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1165\/rcmb.2013-0025OC","article-title":"Dysregulation of galectin-3: implications for Hermansky\u2013Pudlak syndrome pulmonary fibrosis","volume":"50","author":"Cullinane","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020402524458400_bib39","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1164\/rccm.201407-1287OC","article-title":"Circulating fibrocytes as biomarker of prognosis in Hermansky\u2013Pudlak syndrome","volume":"190","author":"Trimble","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402524458400_bib40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0749.1998.tb00713.x","article-title":"Mouse models of Hermansky Pudlak syndrome: a review","volume":"11","author":"Swank","year":"1998","journal-title":"Pigment Cell Res"},{"key":"2026020402524458400_bib41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng835","article-title":"Hermansky\u2013Pudlak syndrome is caused by mutations in HPS4, the human homolog of the mouse light-ear gene","volume":"30","author":"Suzuki","year":"2002","journal-title":"Nat Genet"},{"key":"2026020402524458400_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ng1087","article-title":"Ru2 and Ru encode mouse orthologs of the genes mutated in human Hermansky\u2013Pudlak syndrome types 5 and 6","volume":"33","author":"Zhang","year":"2003","journal-title":"Nat Genet"},{"key":"2026020402524458400_bib43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/hmg\/6.5.793","article-title":"Mouse pale ear (ep) is homologous to human Hermansky\u2013Pudlak syndrome and contains a rare \u201cAT-AC\u201d intron","volume":"6","author":"Feng","year":"1997","journal-title":"Hum Mol Genet"},{"key":"2026020402524458400_bib44","doi-asserted-by":"crossref","first-page":"9238","DOI":"10.1073\/pnas.94.17.9238","article-title":"The mouse pale ear (ep) mutation is the homologue of human Hermansky\u2013Pudlak syndrome","volume":"94","author":"Gardner","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020402524458400_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/hmg\/8.2.323","article-title":"The \u03b23A subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse hypopigmentation mutant pearl, a model for Hermansky\u2013Pudlak syndrome and night blindness","volume":"8","author":"Feng","year":"1999","journal-title":"Hum Mol Genet"},{"key":"2026020402524458400_bib46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/geno.2001.6644","article-title":"The gene mutated in cocoa mice, carrying a defect of organelle biogenesis, is a homologue of the human Hermansky\u2013Pudlak syndrome-3 gene","volume":"78","author":"Suzuki","year":"2001","journal-title":"Genomics"},{"key":"2026020402524458400_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1440-1827.2005.01811.x","article-title":"Lung pathology of pale ear mouse (model of Hermansky\u2013Pudlak syndrome 1) and beige mouse (model of Chediak\u2013Higashi syndrome): severity of giant lamellar body degeneration of type II pneumocytes correlates with interstitial inflammation","volume":"55","author":"Tang","year":"2005","journal-title":"Pathol Int"},{"key":"2026020402524458400_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1165\/rcmb.2006-0469OC","article-title":"Susceptibility of Hermansky\u2013Pudlak mice to bleomycin-induced type II cell apoptosis and fibrosis","volume":"37","author":"Young","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020402524458400_bib49","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.4049\/jimmunol.176.7.4361","article-title":"Lung-restricted macrophage activation in the pearl mouse model of Hermansky\u2013Pudlak syndrome","volume":"176","author":"Young","year":"2006","journal-title":"J Immunol"},{"key":"2026020402524458400_bib50","doi-asserted-by":"crossref","first-page":"L643","DOI":"10.1152\/ajplung.00024.2003","article-title":"Aberrant lung structure, composition, and function in a murine model of Hermansky\u2013Pudlak syndrome","volume":"285","author":"Lyerla","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026020402524458400_bib51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1164\/rccm.200909-1414OC","article-title":"Epithelial stress and apoptosis underlie Hermansky\u2013Pudlak syndrome-associated interstitial pneumonia","volume":"182","author":"Mahavadi","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402524458400_bib52","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1164\/rccm.201207-1206OC","article-title":"The alveolar epithelium determines susceptibility to lung fibrosis in Hermansky\u2013Pudlak syndrome","volume":"186","author":"Young","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402524458400_bib53","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1172\/JCI79792","article-title":"Chitinase 3-like-1 and its receptors in Hermansky\u2013Pudlak syndrome-associated lung disease","volume":"125","author":"Zhou","year":"2015","journal-title":"J Clin Invest"},{"key":"2026020402524458400_bib54","doi-asserted-by":"crossref","first-page":"L519","DOI":"10.1152\/ajplung.00213.2015","article-title":"MAP1LC3B overexpression protects against Hermansky\u2013Pudlak syndrome type-1-induced defective autophagy in vitro","volume":"310","author":"Ahuja","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026020402524458400_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood.V61.2.229.229","article-title":"Preoperative hemostatic evaluation: which tests, if any?","volume":"61","author":"Rapaport","year":"1983","journal-title":"Blood"},{"key":"2026020402524458400_bib56","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ajh.2830260403","article-title":"Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky\u2013Pudlak syndrome","volume":"26","author":"Witkop","year":"1987","journal-title":"Am J Hematol"},{"key":"2026020402524458400_bib57","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1309\/Y9EC63RW3XG1V313","article-title":"Platelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field","volume":"123","author":"Zhou","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"2026020402524458400_bib58","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm0315-204","article-title":"Insurance companies are slow to cover next-generation sequencing","volume":"21","author":"Chakradhar","year":"2015","journal-title":"Nat Med"},{"key":"2026020402524458400_bib59","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2214\/ajr.179.4.1790887","article-title":"Hermansky\u2013Pudlak syndrome: radiography and CT of the chest compared with pulmonary function tests and genetic studies","volume":"179","author":"Avila","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"2026020402524458400_bib60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1378\/chest.117.1.129","article-title":"Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky\u2013Pudlak syndrome, due to mutations in HPS-1","volume":"117","author":"Brantly","year":"2000","journal-title":"Chest"},{"key":"2026020402524458400_bib61","first-page":"42","article-title":"The Hermansky\u2013Pudlak syndrome: radiographic features","volume":"37","author":"Leitman","year":"1986","journal-title":"Can Assoc Radiol J"},{"key":"2026020402524458400_bib62","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.healun.2004.11.015","article-title":"Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky\u2013Pudlak syndrome","volume":"24","author":"Lederer","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"2026020402524458400_bib63","first-page":"822","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"Tomczyk","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026020402524458400_bib64","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"2026020402524458400_bib65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1465-9921-12-143","article-title":"Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment","volume":"12","author":"Azuma","year":"2011","journal-title":"Respir Res"},{"key":"2026020402524458400_bib66","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ymgme.2011.02.003","article-title":"Pirfenidone for the treatment of Hermansky\u2013Pudlak syndrome pulmonary fibrosis","volume":"103","author":"O\u2019Brien","year":"2011","journal-title":"Mol Genet Metab"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/10\/1839\/66663550\/annalsats_13_10_1839.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/10\/1839\/66663550\/annalsats_13_10_1839.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:52:57Z","timestamp":1770191577000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/13\/10\/1839\/8448729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,1]]},"references-count":66,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,1]]},"published-print":{"date-parts":[[2016,10,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201603-186fr","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,10]]},"published":{"date-parts":[[2016,10,1]]}}}